About 68 per cent of patients on Dupixent experienced side effects, which was consistent ... has approved Dupixent (dupilumab) injections as an add-on therapy for adults with chronic obstructive ...

It acts as an interleukin 4-receptor alpha antagonist, blocking the inflammatory effects of interleukin-4 and interleukin-13, which helps reduce inflammation in the body. Dupilumab can be used ...

‘Dupilumab reduced symptoms by a magnitude ... She has also been left with long-term side-effects from a steroid- based ...